Hao Nguyen, MD, PhD

Title(s)Associate Professor, Urology
SchoolSchool of Medicine
Address550 16th. Street
San Francisco CA 94158
Phone415-514-5541
ORCID ORCID Icon0000-0001-8275-5375 Additional info
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Boston University, BostonMD-PhD2007Molecular Medicine
    University of California, Davis, SacramentoResidency2013Urologic Surgery
    University of California, San Francisco, San FranciscoFellowship2015Urologic Oncology

    Collapse Overview 

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Natural history of an immediately detectable PSA following radical prostatectomy in a contemporary cohort. Prostate. 2021 Jul 20. Lonergan PE, Cowan JE, Washington SL, Greenberg SA, Nguyen HG, Carroll PR. PMID: 34288004.
      View in: PubMed   Mentions:    Fields:    
    2. Association of Age With Risk of Adverse Pathological Findings in Men Undergoing Delayed Radical Prostatectomy Following Active Surveillance. Urology. 2021 Jun 09. de la Calle CM, Shee K, Chu CE, Cowan JE, Nguyen HG, Carroll PR. PMID: 34118228.
      View in: PubMed   Mentions:    Fields:    
    3. Residual Benign Prostate Glandular Tissue after Radical Prostatectomy Is not Associated with the Development of Detectable Postoperative Serum Prostate Specific Antigen. J Urol. 2021 Apr 27; 101097JU0000000000001793. Greenberg SA, Washington SL, Lonergan PE, Cowan JE, Baskin AS, Nguyen HG, Odisho AY, Simko JP, Carroll PR. PMID: 33905262.
      View in: PubMed   Mentions:    Fields:    
    4. The Long-Term Risks of Metastases in Men on Active Surveillance for Early Stage Prostate Cancer. J Urol. 2020 12; 204(6):1222-1228. Maggi M, Cowan JE, Fasulo V, Washington SL, Lonergan PE, Sciarra A, Nguyen HG, Carroll PR. PMID: 33157570.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    5. Influence of pelvic lymph node dissection and node-positive disease on biochemical recurrence, secondary treatment, and survival after radical prostatectomy in men with prostate cancer. Prostate. 2021 02; 81(2):102-108. Washington SL, Cowan JE, Herlemann A, Zuniga KB, Masic S, Nguyen HG, Carroll PR. PMID: 33075151.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    6. Characteristics of Cancer Progression on Serial Biopsy in Men on Active Surveillance for Early-stage Prostate Cancer: Implications for Focal Therapy. Eur Urol Oncol. 2020 Oct 14. Fasulo V, Cowan JE, Maggi M, Washington SL, Nguyen HG, Shinohara K, Lazzeri M, Casale P, Carroll PR. PMID: 33069628.
      View in: PubMed   Mentions:    Fields:    
    7. Reply by Authors. J Urol. 2020 12; 204(6):1221. Lonergan PE, Washington SL, Cowan JE, Zhao S, Nguyen HG, Shinohara K, Cooperberg MR, Carroll PR. PMID: 32969756.
      View in: PubMed   Mentions:    Fields:    
    8. Clinical Utility of 4Kscore®, ExosomeDx™ and Magnetic Resonance Imaging for the Early Detection of High Grade Prostate Cancer. J Urol. 2021 02; 205(2):452-460. de la Calle CM, Fasulo V, Cowan JE, Lonergan PE, Maggi M, Gadzinski AJ, Yeung RA, Saita A, Cooperberg MR, Shinohara K, Carroll PR, Nguyen HG. PMID: 32897802.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    9. How Often Does Magnetic Resonance Imaging Detect Prostate Cancer Missed by Transrectal Ultrasound? Eur Urol Focus. 2020 Aug 28. Herlemann A, Overland MR, Washington SL, Cowan JE, Westphalen AC, Carroll PR, Nguyen HG, Shinohara K, Cooperberg MR. PMID: 32868222.
      View in: PubMed   Mentions:    Fields:    
    10. The splicing modulator sulfonamide indisulam reduces AR-V7 in prostate cancer cells. Bioorg Med Chem. 2020 10 15; 28(20):115712. Melnyk JE, Steri V, Nguyen HG, Hann B, Feng FY, Shokat KM. PMID: 33069070.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimalsCells
    11. Risk Factors for Biopsy Reclassification over Time in Men on Active Surveillance for Early Stage Prostate Cancer. J Urol. 2020 12; 204(6):1216-1221. Lonergan PE, Washington SL, Cowan JE, Zhao S, Nguyen HG, Shinohara K, Cooperberg MR, Carroll PR. PMID: 32519915.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    12. MRI-Based Prostate-Specific Antigen Density Predicts Gleason Score Upgrade in an Active Surveillance Cohort. AJR Am J Roentgenol. 2020 03; 214(3):574-578. Washington SL, Baskin AS, Ameli N, Nguyen HG, Westphalen AC, Shinohara K, Carroll PR. PMID: 31913068.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    13. Differences in negative predictive value of prostate MRI based in men with suspected or known cancer. Radiol Bras. 2019 Sep-Oct; 52(5):281-286. Baghdanian AA, Kim YJ, Baghdanian AH, Nguyen HN, Shinohara K, Westphalen AC. PMID: 31656343.
      View in: PubMed   Mentions:
    14. Evaluating the Safety of Active Surveillance: Outcomes of Deferred Radical Prostatectomy after an Initial Period of Surveillance. J Urol. 2019 09; 202(3):506-510. Balakrishnan AS, Cowan JE, Cooperberg MR, Shinohara K, Nguyen HG, Carroll PR. PMID: 30958738.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    15. Detection of clinically signifi cant prostate cancer with PIRADS v2 scores, PSA density, and ADC values in regions with and without mpMRI visible lesions. Int Braz J Urol. 2019 Jul-Aug; 45(4):713-723. Westphalen AC, Fazel F, Nguyen H, Cabarrus M, Hanley-Knutson K, Shinohara K, Carroll PR. PMID: 31136112.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    16. The use of prostate MR for targeting prostate biopsies. BJR Open. 2019; 1(1):20180044. Kelley RP, Zagoria RJ, Nguyen HG, Shinohara K, Westphalen AC. PMID: 33178929.
      View in: PubMed   Mentions:
    17. A Mobile Health Intervention for Prostate Biopsy Patients Reduces Appointment Cancellations: Cohort Study. J Med Internet Res. 2019 06 02; 21(6):e14094. Balakrishnan AS, Nguyen HG, Shinohara K, Au Yeung R, Carroll PR, Odisho AY. PMID: 31199294.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    18. Assessment of 68Ga-PSMA-11 PET Accuracy in Localizing Recurrent Prostate Cancer: A Prospective Single-Arm Clinical Trial. JAMA Oncol. 2019 Jun 01; 5(6):856-863. Fendler WP, Calais J, Eiber M, Flavell RR, Mishoe A, Feng FY, Nguyen HG, Reiter RE, Rettig MB, Okamoto S, Emmett L, Zacho HD, Ilhan H, Wetter A, Rischpler C, Schoder H, Burger IA, Gartmann J, Smith R, Small EJ, Slavik R, Carroll PR, Herrmann K, Czernin J, Hope TA. PMID: 30920593.
      View in: PubMed   Mentions: 80     Fields:    Translation:HumansCTClinical Trials
    19. NMR quantification of lactate production and efflux and glutamate fractional enrichment in living human prostate biopsies cultured with [1,6-13 C2 ]glucose. Magn Reson Med. 2019 08; 82(2):566-576. Bancroft Brown J, Sriram R, VanCriekinge M, Delos Santos R, Sun J, Delos Santos J, Tabatabai ZL, Shinohara K, Nguyen H, Peehl DM, Kurhanewicz J. PMID: 30924180.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    20. Location of Recurrence by Gallium-68 PSMA-11 PET Scan in Prostate Cancer Patients Eligible for Salvage Radiotherapy. Urology. 2019 07; 129:165-171. Boreta L, Gadzinski AJ, Wu SY, Xu M, Greene K, Quanstrom K, Nguyen HG, Carroll PR, Hope TA, Feng FY. PMID: 30928607.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCTClinical Trials
    21. Genomic Risk Predicts Molecular Imaging-detected Metastatic Nodal Disease in Prostate Cancer. Eur Urol Oncol. 2019 11; 2(6):685-690. Xu MJ, Kornberg Z, Gadzinski AJ, Diao D, Cowan JE, Wu SY, Boreta L, Spratt DE, Behr SC, Nguyen HG, Cooperberg MR, Davicioni E, Roach M, Hope TA, Carroll PR, Feng FY. PMID: 31411984.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    22. Translation control of the immune checkpoint in cancer and its therapeutic targeting. Nat Med. 2019 02; 25(2):301-311. Xu Y, Poggio M, Jin HY, Shi Z, Forester CM, Wang Y, Stumpf CR, Xue L, Devericks E, So L, Nguyen HG, Griselin A, Gordan JD, Umetsu SE, Reich SH, Worland ST, Asthana S, Barna M, Webster KR, Cunningham JT, Ruggero D. PMID: 30643286.
      View in: PubMed   Mentions: 48     Fields:    Translation:AnimalsCells
    23. Impact of Staging 68Ga-PSMA-11 PET Scans on Radiation Treatment Plansin Patients With Prostate Cancer. Urology. 2019 03; 125:154-162. Wu SY, Boreta L, Shinohara K, Nguyen H, Gottschalk AR, Hsu IC, Roach M, Westphalen AC, Feng FY, Carroll PR, Chang AJ, Hope TA. PMID: 30580002.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    24. Phase I Study of CTT1057, an 18F-Labeled Imaging Agent with Phosphoramidate Core Targeting Prostate-Specific Membrane Antigen in Prostate Cancer. J Nucl Med. 2019 07; 60(7):910-916. Behr SC, Aggarwal R, VanBrocklin HF, Flavell RR, Gao K, Small EJ, Blecha J, Jivan S, Hope TA, Simko JP, Kurhanewicz J, Noworolski SM, Korn NJ, De Los Santos R, Cooperberg MR, Carroll PR, Nguyen HG, Greene KL, Langton-Webster B, Berkman CE, Seo Y. PMID: 30464040.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    25. Diagnostic Accuracy of 68Ga-PSMA-11 PET/MRI Compared with Multiparametric MRI in the Detection of Prostate Cancer. Radiology. 2018 12; 289(3):730-737. Hicks RM, Simko JP, Westphalen AC, Nguyen HG, Greene KL, Zhang L, Carroll PR, Hope TA. PMID: 30226456.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    26. Comparing Prognostic Utility of a Single-marker Immunohistochemistry Approach with Commercial Gene Expression Profiling Following Radical Prostatectomy. Eur Urol. 2018 11; 74(5):668-675. Leapman MS, Nguyen HG, Cowan JE, Xue L, Stohr B, Simko J, Cooperberg MR, Carroll PR. PMID: 30181067.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    27. Effects of Initial Gleason Grade on Outcomes during Active Surveillance for Prostate Cancer. Eur Urol Oncol. 2018 10; 1(5):386-394. Masic S, Cowan JE, Washington SL, Nguyen HG, Shinohara K, Cooperberg MR, Carroll PR. PMID: 31158077.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    28. Development of a stress response therapy targeting aggressive prostate cancer. Sci Transl Med. 2018 05 02; 10(439). Nguyen HG, Conn CS, Kye Y, Xue L, Forester CM, Cowan JE, Hsieh AC, Cunningham JT, Truillet C, Tameire F, Evans MJ, Evans CP, Yang JC, Hann B, Koumenis C, Walter P, Carroll PR, Ruggero D. PMID: 29720449.
      View in: PubMed   Mentions: 35     Fields:    Translation:HumansAnimalsCells
    29. Development and Validation of a Novel Integrated Clinical-Genomic Risk Group Classification for Localized Prostate Cancer. J Clin Oncol. 2018 02 20; 36(6):581-590. Spratt DE, Zhang J, Santiago-Jiménez M, Dess RT, Davis JW, Den RB, Dicker AP, Kane CJ, Pollack A, Stoyanova R, Abdollah F, Ross AE, Cole A, Uchio E, Randall JM, Nguyen H, Zhao SG, Mehra R, Glass AG, Lam LLC, Chelliserry J, du Plessis M, Choeurng V, Aranes M, Kolisnik T, Margrave J, Alter J, Jordan J, Buerki C, Yousefi K, Haddad Z, Davicioni E, Trabulsi EJ, Loeb S, Tewari A, Carroll PR, Weinmann S, Schaeffer EM, Klein EA, Karnes RJ, Feng FY, Nguyen PL. PMID: 29185869.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    30. Impact of Lesion Visibility on Transrectal Ultrasound on the Prediction of Clinically Significant Prostate Cancer (Gleason Score 3 + 4 or Greater) with Transrectal Ultrasound-Magnetic Resonance Imaging Fusion Biopsy. J Urol. 2018 03; 199(3):699-705. Garcia-Reyes K, Nguyen HG, Zagoria RJ, Shinohara K, Carroll PR, Behr SC, Westphalen AC. PMID: 28941918.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    31. Validation of GEMCaP as a DNA Based Biomarker to Predict Prostate Cancer Recurrence after Radical Prostatectomy. J Urol. 2018 03; 199(3):719-725. Nguyen HG, Welty C, Lindquist K, Ngo V, Gilbert E, Bengtsson H, Magi-Galluzzi C, Jean-Gilles J, Yao J, Cooperberg M, Messing E, Klein EA, Carroll PR, Paris PL. PMID: 28941923.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    32. Active Surveillance in Younger Men With Prostate Cancer. J Clin Oncol. 2017 Jun 10; 35(17):1898-1904. Leapman MS, Cowan JE, Nguyen HG, Shinohara KK, Perez N, Cooperberg MR, Catalona WJ, Carroll PR. PMID: 28346806.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    33. A Randomized Study of Intraoperative Autologous Retropubic Urethral Sling on Urinary Control after Robotic Assisted Radical Prostatectomy. J Urol. 2017 02; 197(2):369-375. Nguyen HG, Punnen S, Cowan JE, Leapman M, Cary C, Welty C, Weinberg V, Cooperberg MR, Meng MV, Greene KL, Garcia M, Carroll PR. PMID: 27693447.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    34. Magnetic Resonance Imaging-Ultrasound Fusion Biopsy During Prostate Cancer Active Surveillance. Eur Urol. 2017 08; 72(2):275-281. Tran GN, Leapman MS, Nguyen HG, Cowan JE, Shinohara K, Westphalen AC, Carroll PR. PMID: 27595378.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    35. 18F Fluorocholine Dynamic Time-of-Flight PET/MR Imaging in Patients with Newly Diagnosed Intermediate- to High-Risk Prostate Cancer: Initial Clinical-Pathologic Comparisons. Radiology. 2017 Feb; 282(2):429-436. Choi JY, Yang J, Noworolski SM, Behr S, Chang AJ, Simko JP, Nguyen HG, Carroll PR, Kurhanewicz J, Seo Y. PMID: 27513849.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
    36. Validity of the Cancer of the Prostate Risk Assessment Score Derived From Targeted Biopsy: Modeling Evidence From Ultrasound Lesion-Directed Biopsy. Clin Genitourin Cancer. 2017 02; 15(1):93-99. Leapman MS, Ameli N, Shinohara K, Nguyen HG, Meng MV, Cooperberg MR, Carroll PR. PMID: 27522449.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    37. Clinical Utility of Biomarkers in Localized Prostate Cancer. Curr Oncol Rep. 2016 May; 18(5):30. Leapman MS, Nguyen HG, Cooperberg MR. PMID: 27023445.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    38. Editorial Comment. Urology. 2016 07; 93:84-5. Leapman MS, Nguyen HG. PMID: 27113494.
      View in: PubMed   Mentions:    Fields:    
    39. Cell type-specific abundance of 4EBP1 primes prostate cancer sensitivity or resistance to PI3K pathway inhibitors. Sci Signal. 2015 Nov 17; 8(403):ra116. Hsieh AC, Nguyen HG, Wen L, Edlind MP, Carroll PR, Kim W, Ruggero D. PMID: 26577921.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    40. miR-124 and Androgen Receptor Signaling Inhibitors Repress Prostate Cancer Growth by Downregulating Androgen Receptor Splice Variants, EZH2, and Src. Cancer Res. 2015 Dec 15; 75(24):5309-17. Shi XB, Ma AH, Xue L, Li M, Nguyen HG, Yang JC, Tepper CG, Gandour-Edwards R, Evans CP, Kung HJ, deVere White RW. PMID: 26573802.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansAnimalsCells
    41. YB-1 and MTA1 protein levels and not DNA or mRNA alterations predict for prostate cancer recurrence. Oncotarget. 2015 Apr 10; 6(10):7470-80. Sheridan CM, Grogan TR, Nguyen HG, Galet C, Rettig MB, Hsieh AC, Ruggero D. PMID: 25797255.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    42. Cardiopulmonary Bypass has No Significant Impact on Survival in Patients Undergoing Nephrectomy and Level III-IV Inferior Vena Cava Thrombectomy: Multi-Institutional Analysis. J Urol. 2015 Aug; 194(2):304-308. Nguyen HG, Tilki D, Dall'Era MA, Durbin-Johnson B, Carballido JA, Chandrasekar T, Chromecki T, Ciancio G, Daneshmand S, Gontero P, Gonzalez J, Haferkamp A, Hohenfellner M, Huang WC, Espinós EL, Mandel P, Martinez-Salamanca JI, Master VA, McKiernan JM, Montorsi F, Novara G, Pahernik S, Palou J, Pruthi RS, Rodriguez-Faba O, Russo P, Scherr DS, Shariat SF, Spahn M, Terrone C, Vergho D, Wallen EM, Xylinas E, Zigeuner R, Libertino JA, Evans CP. PMID: 25797392.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    43. Diagnostic associations of gene expression signatures in prostate cancer tissue. Curr Opin Urol. 2015 Jan; 25(1):65-70. Nguyen HG, Welty CJ, Cooperberg MR. PMID: 25405934.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    44. Extended followup and risk factors for disease reclassification in a large active surveillance cohort for localized prostate cancer. J Urol. 2015 Mar; 193(3):807-11. Welty CJ, Cowan JE, Nguyen H, Shinohara K, Perez N, Greene KL, Chan JM, Meng MV, Simko JP, Cooperberg MR, Carroll PR. PMID: 25261803.
      View in: PubMed   Mentions: 50     Fields:    Translation:Humans
    45. Impact of synchronous metastasis distribution on cancer specific survival in renal cell carcinoma after radical nephrectomy with tumor thrombectomy. J Urol. 2015 Feb; 193(2):436-42. Tilki D, Hu B, Nguyen HG, Dall'Era MA, Bertini R, Carballido JA, Chandrasekar T, Chromecki T, Ciancio G, Daneshmand S, Gontero P, Gonzalez J, Haferkamp A, Hohenfellner M, Huang WC, Koppie TM, Linares E, Lorentz CA, Mandel P, Martinez-Salamanca JI, Master VA, Matloob R, McKiernan JM, Mlynarczyk CM, Montorsi F, Novara G, Pahernik S, Palou J, Pruthi RS, Ramaswamy K, Rodriguez Faba O, Russo P, Shariat SF, Spahn M, Terrone C, Thieu W, Vergho D, Wallen EM, Xylinas E, Zigeuner R, Libertino JA, Evans CP. PMID: 25063493.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    46. Lessons learned from the International Renal Cell Carcinoma-Venous Thrombus Consortium (IRCC-VTC). Curr Urol Rep. 2014 May; 15(5):404. Martínez-Salamanca JI, Linares E, González J, Bertini R, Carballido JA, Chromecki T, Ciancio G, Daneshmand S, Evans CP, Gontero P, Haferkamp A, Hohenfellner M, Huang WC, Koppie TM, Master VA, Matloob R, McKiernan JM, Mlynarczyk CM, Montorsi F, Nguyen HG, Novara G, Pahernik S, Palou J, Pruthi RS, Ramaswamy K, Faba OR, Russo P, Shariat SF, Spahn M, Terrone C, Tilki D, Vergho D, Wallen EM, Xylinas E, Zigeuner R, Libertino JA. PMID: 24682884.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    47. Management of an increasing prostate-specific antigen level after negative prostate biopsy. Urol Clin North Am. 2014 May; 41(2):327-38. Shinohara K, Nguyen H, Masic S. PMID: 24725493.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    48. Targeting autophagy overcomes Enzalutamide resistance in castration-resistant prostate cancer cells and improves therapeutic response in a xenograft model. Oncogene. 2014 Sep 04; 33(36):4521-30. Nguyen HG, Yang JC, Kung HJ, Shi XB, Tilki D, Lara PN, DeVere White RW, Gao AC, Evans CP. PMID: 24662833.
      View in: PubMed   Mentions: 66     Fields:    Translation:HumansAnimalsCells
    49. The effect of BMI on clinicopathologic and functional outcomes after open radical prostatectomy. Urol Oncol. 2014 Apr; 32(3):297-302. Mandel P, Kretschmer A, Chandrasekar T, Nguyen HG, Buchner A, Stief CG, Tilki D. PMID: 24332640.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    50. Impact of histologic subtype on cancer-specific survival in patients with renal cell carcinoma and tumor thrombus. Eur Urol. 2014 Sep; 66(3):577-83. Tilki D, Nguyen HG, Dall'Era MA, Bertini R, Carballido JA, Chromecki T, Ciancio G, Daneshmand S, Gontero P, Gonzalez J, Haferkamp A, Hohenfellner M, Huang WC, Koppie TM, Lorentz CA, Mandel P, Martinez-Salamanca JI, Master VA, Matloob R, McKiernan JM, Mlynarczyk CM, Montorsi F, Novara G, Pahernik S, Palou J, Pruthi RS, Ramaswamy K, Rodriguez Faba O, Russo P, Shariat SF, Spahn M, Terrone C, Vergho D, Wallen EM, Xylinas E, Zigeuner R, Libertino JA, Evans CP. PMID: 23871402.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    51. Outcomes after pediatric ureteral reimplantation: a population based analysis. J Urol. 2011 Jun; 185(6):2292-7. Nguyen HG, Chamie K, Nguyen KG, Durbin-Johnson B, Kurzrock EA. PMID: 21511291.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    52. Polyploidy: mechanisms and cancer promotion in hematopoietic and other cells. Adv Exp Med Biol. 2010; 676:105-22. Nguyen HG, Ravid K. PMID: 20687472.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansAnimalsCells
    53. Deregulated Aurora-B induced tetraploidy promotes tumorigenesis. FASEB J. 2009 Aug; 23(8):2741-8. Nguyen HG, Makitalo M, Yang D, Chinnappan D, St Hilaire C, Ravid K. PMID: 19332642.
      View in: PubMed   Mentions: 48     Fields:    Translation:HumansAnimalsCells
    54. Differential effects of natriuretic peptides on arterial and venous coronary artery bypass conduits. Ann Thorac Surg. 2009 Mar; 87(3):748-56. Nguyen HG, Korach A, Collura C, Eskenazi BR, Vita JA, Shapira OM. PMID: 19231384.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    55. Vascular smooth muscle cell polyploidy: an adaptive or maladaptive response? J Cell Physiol. 2008 Jun; 215(3):588-92. McCrann DJ, Nguyen HG, Jones MR, Ravid K. PMID: 18181174.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimalsCells
    56. Direct visualization of the endomitotic cell cycle in living megakaryocytes: differential patterns in low and high ploidy cells. . 2008 Aug; 7(15):2352-6. Papadantonakis N, Makitalo M, McCrann DJ, Liu K, Nguyen HG, Martin G, Patel-Hett S, Italiano JE, Ravid K. PMID: 18677109.
      View in: PubMed   Mentions:
    57. Survivin overexpression alone does not alter megakaryocyte ploidy nor interfere with erythroid/megakaryocytic lineage development in transgenic mice. Blood. 2008 Apr 15; 111(8):4092-5. McCrann DJ, Yezefski T, Nguyen HG, Papadantonakis N, Liu H, Wen Q, Crispino JD, Ravid K. PMID: 18245663.
      View in: PubMed   Mentions: 6     Fields:    Translation:AnimalsCells
    58. Diastolic dysfunction after coronary artery bypass grafting--the effect of glucose-insulin-potassium infusion. J Card Surg. 2007 May-Jun; 22(3):185-91. Tsang MW, Davidoff R, Korach A, Apstein CS, Hesselvik JF, Nguyen H, Shemin RJ, Shapira OM. PMID: 17488411.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    59. Increased polyploidy in aortic vascular smooth muscle cells during aging is marked by cellular senescence. Aging Cell. 2007 Apr; 6(2):257-60. Yang D, McCrann DJ, Nguyen H, St Hilaire C, DePinho RA, Jones MR, Ravid K. PMID: 17291294.
      View in: PubMed   Mentions: 21     Fields:    Translation:AnimalsCells
    60. Tetraploidy/aneuploidy and stem cells in cancer promotion: The role of chromosome passenger proteins. J Cell Physiol. 2006 Jul; 208(1):12-22. Nguyen HG, Ravid K. PMID: 16331679.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCells
    61. The A2B adenosine receptor protects against inflammation and excessive vascular adhesion. J Clin Invest. 2006 Jul; 116(7):1913-23. Yang D, Zhang Y, Nguyen HG, Koupenova M, Chauhan AK, Makitalo M, Jones MR, St Hilaire C, Seldin DC, Toselli P, Lamperti E, Schreiber BM, Gavras H, Wagner DD, Ravid K. PMID: 16823489.
      View in: PubMed   Mentions: 177     Fields:    Translation:AnimalsCells
    62. Mechanism of Aurora-B degradation and its dependency on intact KEN and A-boxes: identification of an aneuploidy-promoting property. Mol Cell Biol. 2005 Jun; 25(12):4977-92. Nguyen HG, Chinnappan D, Urano T, Ravid K. PMID: 15923616.
      View in: PubMed   Mentions: 62     Fields:    Translation:HumansAnimalsCells
    63. Conditional overexpression of transgenes in megakaryocytes and platelets in vivo. Blood. 2005 Sep 01; 106(5):1559-64. Nguyen HG, Yu G, Makitalo M, Yang D, Xie HX, Jones MR, Ravid K. PMID: 15890684.
      View in: PubMed   Mentions: 12     Fields:    Translation:AnimalsCells
    64. Vascular smooth muscle cell polyploidization involves changes in chromosome passenger proteins and an endomitotic cell cycle. Exp Cell Res. 2005 May 01; 305(2):277-91. Nagata Y, Jones MR, Nguyen HG, McCrann DJ, St Hilaire C, Schreiber BM, Hashimoto A, Inagaki M, Earnshaw WC, Todokoro K, Ravid K. PMID: 15817153.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansAnimalsCells
    65. Aberrant quantity and localization of Aurora-B/AIM-1 and survivin during megakaryocyte polyploidization and the consequences of Aurora-B/AIM-1-deregulated expression. Blood. 2004 May 15; 103(10):3717-26. Zhang Y, Nagata Y, Yu G, Nguyen HG, Jones MR, Toselli P, Jackson CW, Tatsuka M, Todokoro K, Ravid K. PMID: 14751927.
      View in: PubMed   Mentions: 26     Fields:    Translation:AnimalsCells
    66. A selective effect of Mpl ligand on mRNA stabilization during megakaryocyte differentiation. FEBS Lett. 2002 Sep 11; 527(1-3):279-83. Kaluzhny Y, Hechler B, Lu J, Nguyen HG, Cataldo LM, Ravid K. PMID: 12220674.
      View in: PubMed   Mentions: 1     Fields:    Translation:AnimalsCells
    67. Quercetin inhibits inducible ICAM-1 expression in human endothelial cells through the JNK pathway. Am J Physiol. 1999 09; 277(3):C403-11. Kobuchi H, Roy S, Sen CK, Nguyen HG, Packer L. PMID: 10484327.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansCells
    Hao's Networks
    Concepts (338)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (66)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version v3.0.0-841-gd6c3184f on PROFILES-PWEB01.

    Copyright © The Regents of the University of California